NCT03060603View on ClinicalTrials.gov

Proliferative Effects of Erythropoietin on Human Endometrium

CompletedOBSERVATIONAL
Enrollment

14

Participants

Timeline

Start Date

February 23, 2017

Primary Completion Date

December 29, 2017

Study Completion Date

January 15, 2018

Conditions
AnemiaEndometrial Diseases
Interventions
DRUG

Erythropoietin

Recombinant Human Erythropoietin, three times in a week, until the correction of anemia, approximately two months.

Trial Locations (1)

34758

Fatih Sultan Mehmet Training and Research Hospital, Istanbul

All Listed Sponsors
collaborator

Dr. Lutfi Kirdar Kartal Training and Research Hospital

OTHER_GOV

lead

Fatih Sultan Mehmet Training and Research Hospital

OTHER

NCT03060603 - Proliferative Effects of Erythropoietin on Human Endometrium | Biotech Hunter | Biotech Hunter